Study on a 4-Week Recovery Test of Sweet Bee Venom after a 13-Week, Repeated, Intramuscular Dose Toxicity Test in Sprague-Dawley Rats
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives: This study was performed to check for reversibility in the changes induced by a 13-week, repeated, dose toxicity test of Sweet Bee Venom (SBV) in Sprague-Dawley (SD) rats. Methods: Fifteen male and 15 female SD rats were treated with 0.28 mg/kg of SBV (high-dosage group) and the same numbers of male and female SD rats were treated with 0.2 mL/kg of normal saline (control group) for 13 weeks. We selected five male and five female SD rats from the high-dosage group and the same numbers of male and female SD rats from the control group, and we observed these rats for four weeks. We conducted body-weight measurements, ophthalmic examinations, urinalyses and hematology, biochemistry, histology tests. Results: (1) Hyperemia and movement disorder were observed in the 13-week, repeated, dose toxicity test, but these symptoms were not observed during the recovery period. (2) The rats in the high-dose group showed no significant changes in weight compared to the control group. (3) No significant differences in the ophthalmic parameters, urine analyses, CBCs, and biochemistry were observed among the recovery groups. (4) No changes in organ weights were observed during the recovery period. (5) Histological examination of the thigh muscle indicated cell infiltration, inflammation, degeneration, necrosis of muscle fiber, and fibrosis during the treatment period, but these changes were not observed during the recovery period. The fatty liver change that was observed during the toxicity test was not observed during the recovery period. No other organ abnormalities were observed. Conclusion: The changes that occurred during the 13-week, repeated, dose toxicity test are reversible, and SBV can be safely used as a treatment modality.
Abstract
Objectives: This study was performed to check for reversibility in the changes induced by a 13-week, repeated, dose toxicity test of Sweet Bee Venom (SBV) in Sprague-Dawley (SD) rats. Methods: Fifteen male and 15 female SD rats were treated with 0.28 mg/kg of SBV (high-dosage group) and the same numbers of male and female SD rats were treated with 0.2 mL/kg of normal saline (control group) for 13 weeks. We selected five male and five female SD rats from the high-dosage group and the same numbers of male and female SD rats from the control group, and we observed these rats for four weeks. We conducted body-weight measurements, ophthalmic examinations, urinalyses and hematology, biochemistry, histology tests. Results: (1) Hyperemia and movement disorder were observed in the 13-week, repeated, dose toxicity test, but these symptoms were not observed during the recovery period. (2) The rats in the high-dose group showed no significant changes in weight compared to the control group. (3) No significant differences in the ophthalmic parameters, urine analyses, CBCs, and biochemistry were observed among the recovery groups. (4) No changes in organ weights were observed during the recovery period. (5) Histological examination of the thigh muscle indicated cell infiltration, inflammation, degeneration, necrosis of muscle fiber, and fibrosis during the treatment period, but these changes were not observed during the recovery period. The fatty liver change that was observed during the toxicity test was not observed during the recovery period. No other organ abnormalities were observed. Conclusion: The changes that occurred during the 13-week, repeated, dose toxicity test are reversible, and SBV can be safely used as a treatment modality.
참고문헌 (31)
- Kwon KL., "An experimental study with bee venom therapy on anti-inflammatory and analgesic effects", The Journal of Korean Acupuncture & Moxibustion Society, 15(2), pp.97~103 (1998)
- Ko HK., "Experimental studies on the effect of bee venom therapy on the analgesic, antipyretic and anti-inflammatory action", J Korean Oriental Med, 13(1), pp.283~292 (1992)
- 이성노, "蜂藥鍼治療의 退行性膝關節炎에 대한 臨床的 考察", 대한침구의학회지, 20(5), pp.6~78 (2003), 대한침구의학회
- Wang WH., "Clincal investigation compared with the effects of the bee venom-acupuncture on knee joint with osteoarthritis", The Journal of Korean Acupuncture & Moxibustion Society, 18(3), pp.35~47 (2001)
- 권기록, "Three cases of affections of the hip treated with Korean Bee-Venom therapy", Journal of Pharmacopuncture, 4(3), pp.127~134 (2001), 대한약침학회[DOI]
- 이상훈, "봉독약침이 류마티스 관절염 환자의 관절 통증, 종창 및 급성 염증 반응에 미치는 영향", 대한침구의학회지, 20(2), pp.7~84 (2003), 대한침구의학회
- 이상훈, "무작위 대조 이중맹검 시험을 통한 봉독 약침의 류마티스 관절염 치료 효과 연구", 대한침구의학회지, 20(6), pp.9~88 (2003), 대한침구의학회
- 김경운, "요추간판탈출증에 봉약침의 근위 취혈과 근위 및 원위 취혈의 비교", 대한침구의학회지, 22(6), pp.181~187 (2005), 대한침구의학회
- 이건목, "蜂藥鍼을 위주로 한 腰椎椎間板脫出症 의 突出型 患者(protrusion disc patients) 에 대한 臨床的 考察", 대한침구의학회지, 21(5), pp.13~26 (2004), 대한침구의학회
- 전형준, "봉약침으로 치료한 요추간판탈출증 환자의 임상적 평가", 대한침구의학회지, 20(5), pp.7~72 (2003), 대한침구의학회
- 이대용, "中風後遺症으로 인한 肩臂痛 患者의 蜂藥鍼治療에 대한 臨床的 考察", 대한침구의학회지, 23(4), pp.69~80 (2006), 대한침구의학회
- 정경숙, "뇌졸중 후 중추성 통증 환자에 대한 봉독약침요법 치료 효과에 대한 임상적 연구", 대한침구의학회지, 22(3), pp.69~76 (2005), 대한침구의학회
- 권혜연, "Sweet Bee Venom의 rat를 이용한 4주 반복 근육시술 독성시험", Journal of Pharmacopuncture, 14(1), pp.5~24 (2011), 대한약침학회
- 권기록, "Sweet BV의 성분분석과 항체역가 및 allergy 반응에 대한 임상적 연구", Journal of Pharmacopuncture, 9(2), pp.79~86 (2006), 대한약침학회
- 최영권, "Gel filtration chromatography와 propionic acid", urea polyacrylamide gel electrophoresis를 이용한 봉독 성분의 분리, 2006, pp.9(2), 105~111[DOI]
- 김영진, "Sweet BV의 rat를 이용한 단회 근육시술 독성시험", Journal of Pharmacopuncture, 12(4), pp.5~32 (2009), 대한약침학회
- 윤휘철, "Sweet Bee Venom의 비글견을 이용한 단회근육시술 독성시험", Journal of Pharmacopuncture, 13(4), pp.43~62 (2010), 대한약침학회
- 박재석, "Sweet Bee Venom의 비글견을 이용한 4주 반복 근육시술 독성시험", Journal of Pharmacopuncture, 13(4), pp.5~42 (2010), 대한약침학회
- Korean Pharmacopuncture, "Institute Pharmacopuncturology: principles and clinical applications", pp.147~179 (2012), Elsevier Korea LLC
- Hwang TJ., "An experimental study of production of egg yolk antibody(Ig Y)against bee venom", J Pharmacopunct, 4(2), pp.5~15 (2001)
- 권기록, "Anti-BV의 봉약침 항체 효능에 관한 실험적 연구", Journal of Pharmacopuncture, 8(1), pp.21~30 (2005), 대한약침학회
- Haberman E., "Bee and wasp venoms", Science, 177(4046), pp.314~322 (1972)
- Gauldie J., "The peptide components of bee venom", Eur J Biochem, 61(2), pp.369~376 (1976)
- 이진선, "봉약침(Bee Venom)과 Sweet Bee Venom의 Allergy 반응에 대한 비교연구", Journal of Pharmacopuncture, 9(3), pp.61~77 (2006), 대한약침학회
- 임청산, "Sweet BV의 침감비교 연구", Journal of Pharmacopuncture, 11(2), pp.55~62 (2008), 대한약침학회
- 안중철, "봉독과 Sweet Bee Venom의 항균 및 항산화능 비교연구", Journal of Pharmacopuncture, 9(3), pp.97~104 (2006), 대한약침학회
- 임청산, "Sweet BV가 복부 비만에 미치는 영향", Journal of Pharmacopuncture, 11(2), pp.33~40 (2008), 대한약침학회
- Park HJ., "Antiarthritic effect of bee venom - Inhibition of inflammation mediator generation by suppression of NF-kappa B through interaction with the p50 subunit", ARTHRITIS AND RHEUMATISM, 50(11), pp.3504~3515 (2004), WILEY-LISS
- Park HJ., "JNK pathway is involved on the inhibition of inflammatory target gene expression and NF-kappa B activation by melittin", J Inflamm(Lond), 5, pp.7~ (2008)
- Kim YK., "Toxicology", pp.15~18 (1984), DongHwa Technology Publishing Co
- Heo IH., "Toxicology", pp.9~186 (1993), Shinil Books